The Molecular Imaging Probes and Contrast Agents Database has included 17 new agents on its list, bringing the total number of agents in the database to 841. The new agents are for PET, SPECT and optical imaging.
The Molecular Imaging and Contrast Agent Database has added nine new agents to its list, including agents for SPECT, PET, magnetic resonance and optical imaging. The database currently has 814 agents. The MICAD guest author program also is calling on imaging community members to forward write-ups on various agents for publication.
The market for Alzheimer's disease diagnostics and treatment could grow to $10 billion by 2014, with the diagnostics and biomarker segment taking in $2.8 billion, BCC Research said. Several companies are racing to develop imaging agents for the disease in an effort to break into this multibillion-dollar market. Agents under development include florbetapir from Avid Radiopharmaceuticals, florbetaben from Bayer AG and flutemetamol from General Electric.
Hybridyne Imaging Technologies said the FDA has cleared its cadmium zinc telluride-based compact gamma camera ProxiScan. The technology is used to image how radionuclides are distributed in the body during planar imaging procedures and for intraoperative and endocavity applications.
The NIH's Molecular imaging and contrast agent database has added 13 imaging agents for PET, SPECT and MRI. MICAD is part of the NIH Roadmap's Molecular Libraries and Imaging program. It now includes 796 agents.